Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

AI Applied to Cancer

Identification of diagnostic markers and lipid dysregulation in oesophageal squamous cell carcinoma through lipidomic analysis and machine learning

British Journal of Cancer volume 125, pages 351–357 (2021)Cite this article

Subjects

Abstract

Background

Oesophageal cancer (EC) ranks high in both morbidity and mortality. A non-invasive and high-sensitivity diagnostic approach is necessary to improve the prognosis of EC patients.

Methods

A total of 525 serum samples were subjected to lipidomic analysis. We combined serum lipidomics and machine-learning algorithms to select important metabolite features for the detection of oesophageal squamous cell carcinoma (ESCC), the major subtype of EC in developing countries. A diagnostic model using a panel of selected features was developed and evaluated. Integrative analyses of tissue transcriptome and serum lipidome were conducted to reveal the underlying mechanism of lipid dysregulation.

Results

Our optimised diagnostic model with a panel of 12 lipid biomarkers together with age and gender reaches a sensitivity of 90.7%, 91.3% and 90.7% and an area under receiver-operating characteristic curve of 0.958, 0.966 and 0.818 in detecting ESCC for the training cohort, validation cohort and independent validation cohort, respectively. Integrative analysis revealed matched variation trend of genes encoding key enzymes in lipid metabolism.

Conclusions

We have identified a panel of 12 lipid biomarkers for diagnostic modelling and potential mechanisms of lipid dysregulation in the serum of ESCC patients. This is a reliable, rapid and non-invasive tumour-diagnostic approach for clinical application.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Study design of lipidomic analysis.
Fig. 2: Overview of untargeted serum lipidomic analysis in the exploratory study.
Fig. 3: SVM-based diagnostic modelling and performance evaluation in the validation study.
Fig. 4: Integrative analysis of transcriptomic and lipidomic data of ESCC patients compared to normal controls reveals potential mechanisms of lipid dysregulation.

Similar content being viewed by others

References

  1. Domper Arnal, M. J., Ferrandez Arenas, A. & Lanas Arbeloa, A. Esophageal cancer: risk factors, screening and endoscopic treatment in Western and Eastern countries. World J. Gastroenterol. 21, 7933–7943 (2015).

    Article  Google Scholar 

  2. Rustgi, A. K. & El-Serag, H. B. Esophageal carcinoma. N. Engl. J. Med. 371, 2499–2509 (2014).

    Article  Google Scholar 

  3. Lagergren, J., Smyth, E., Cunningham, D. & Lagergren, P. Oesophageal cancer. Lancet 390, 2383–2396 (2017).

    Article  Google Scholar 

  4. Lao-Sirieix, P. & Fitzgerald, R. C. Screening for oesophageal cancer. Nat. Rev. Clin. Oncol. 9, 278–287 (2012).

    Article  Google Scholar 

  5. Liu, M., He, Z., Guo, C., Xu, R., Li, F., Ning, T. et al. Effectiveness of intensive endoscopic screening for esophageal cancer in China: a community-based study. Am. J. Epidemiol. 188, 776–784 (2019).

    Article  Google Scholar 

  6. Chen, X. X., Zhong, Q., Liu, Y., Yan, S. M., Chen, Z. H., Jin, S. Z. et al. Genomic comparison of esophageal squamous cell carcinoma and its precursor lesions by multi-region whole-exome sequencing. Nat. Commun. 8, 524 (2017).

    Article  CAS  Google Scholar 

  7. Cheng, C., Geng, F., Cheng, X. & Guo, D. Lipid metabolism reprogramming and its potential targets in cancer. Cancer Commun. 38, 27 (2018).

    Article  Google Scholar 

  8. Snaebjornsson, M. T., Janaki-Raman, S. & Schulze, A. Greasing the wheels of the cancer machine: the role of lipid metabolism in cancer. Cell Metab. 31, 62–76 (2020).

    Article  CAS  Google Scholar 

  9. Perrotti, F., Rosa, C., Cicalini, I., Sacchetta, P., Del Boccio, P., Genovesi, D. et al. Advances in lipidomics for cancer biomarkers discovery. Int. J. Mol. Sci. 17, https://doi.org/10.3390/ijms17121992 (2016).

  10. Costello, E. A metabolomics-based biomarker signature discriminates pancreatic cancer from chronic pancreatitis. Gut 67, 2–3 (2018).

    Article  CAS  Google Scholar 

  11. Li, J., Ren, S., Piao, H. L., Wang, F., Yin, P., Xu, C. et al. Integration of lipidomics and transcriptomics unravels aberrant lipid metabolism and defines cholesteryl oleate as potential biomarker of prostate cancer. Sci. Rep. 6, 20984 (2016).

    Article  CAS  Google Scholar 

  12. Sun, C., Li, T., Song, X., Huang, L., Zang, Q., Xu, J. et al. Spatially resolved metabolomics to discover tumor-associated metabolic alterations. Proc. Natl Acad. Sci. USA 116, 52–57 (2019).

    Article  CAS  Google Scholar 

  13. Chu, L. Y., Peng, Y. H., Weng, X. F., Xie, J. J. & Xu, Y. W. Blood-based biomarkers for early detection of esophageal squamous cell carcinoma. World J. Gastroenterol. 26, 1708–1725 (2020).

    Article  Google Scholar 

  14. Mir, S. A., Rajagopalan, P., Jain, A. P., Khan, A. A., Datta, K. K., Mohan, S. V. et al. LC-MS-based serum metabolomic analysis reveals dysregulation of phosphatidylcholines in esophageal squamous cell carcinoma. J. Proteom. 127, 96–102 (2015).

    Article  CAS  Google Scholar 

  15. Zhu, Y., Zhang, H., Chen, N., Hao, J., Jin, H. & Ma, X. Diagnostic value of various liquid biopsy methods for pancreatic cancer: a systematic review and meta-analysis. Medicine 99, e18581 (2020).

    Article  Google Scholar 

  16. Mayerle, J., Kalthoff, H., Reszka, R., Kamlage, B., Peter, E., Schniewind, B. et al. Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis. Gut 67, 128–137 (2018).

    Article  CAS  Google Scholar 

  17. Merker, J. D., Oxnard, G. R., Compton, C., Diehn, M., Hurley, P., Lazar, A. J. et al. Circulating tumor DNA analysis in patients with cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review. J. Clin. Oncol. 36, 1631–1641 (2018).

    Article  CAS  Google Scholar 

  18. Balasenthil, S., Huang, Y., Liu, S., Marsh, T., Chen, J., Stass, S. A. et al. A plasma biomarker panel to identify surgically resectable early-stage pancreatic cancer. J. Natl. Cancer Inst. 109, https://doi.org/10.1093/jnci/djw341 (2017).

  19. Huang, L., Wang, L., Hu, X., Chen, S., Tao, Y., Su, H. et al. Machine learning of serum metabolic patterns encodes early-stage lung adenocarcinoma. Nat. Commun. 11, 3556 (2020).

    Article  CAS  Google Scholar 

  20. Mathe, E. A., Patterson, A. D., Haznadar, M., Manna, S. K., Krausz, K. W., Bowman, E. D. et al. Noninvasive urinary metabolomic profiling identifies diagnostic and prognostic markers in lung cancer. Cancer Res. 74, 3259–3270 (2014).

    Article  CAS  Google Scholar 

  21. Maros, M. E., Capper, D., Jones, D. T. W., Hovestadt, V., von Deimling, A., Pfister, S. M. et al. Machine learning workflows to estimate class probabilities for precision cancer diagnostics on DNA methylation microarray data. Nat. Protoc. 15, 479–512 (2020).

    Article  CAS  Google Scholar 

  22. Li, R., Li, Y., Kristiansen, K. & Wang, J. SOAP: short oligonucleotide alignment program. Bioinformatics 24, 713–714 (2008).

    Article  CAS  Google Scholar 

  23. Kim, D., Langmead, B. & Salzberg, S. L. HISAT: a fast spliced aligner with low memory requirements. Nat. Methods 12, 357–360 (2015).

    Article  CAS  Google Scholar 

  24. Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinform. 12, 323 (2011).

    Article  CAS  Google Scholar 

  25. Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).

    Article  Google Scholar 

  26. Zhou, J. & Yin, Y. Use of liquid chromatography-mass spectrometry-based metabolomics to identify biomarkers of tuberculosis. Methods Mol. Biol. 1859, 241–251 (2019).

    Article  CAS  Google Scholar 

  27. Rohrig, F. & Schulze, A. The multifaceted roles of fatty acid synthesis in cancer. Nat. Rev. Cancer 16, 732–749 (2016).

    Article  Google Scholar 

  28. Yoon, S., Lee, M. Y., Park, S. W., Moon, J. S., Koh, Y. K., Ahn, Y. H. et al. Up-regulation of acetyl-CoA carboxylase alpha and fatty acid synthase by human epidermal growth factor receptor 2 at the translational level in breast cancer cells. J. Biol. Chem. 282, 26122–26131 (2007).

    Article  CAS  Google Scholar 

  29. Nath, A., Li, I., Roberts, L. R. & Chan, C. Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma. Sci. Rep. 5, 14752 (2015).

    Article  CAS  Google Scholar 

  30. Yue, S., Li, J., Lee, S. Y., Lee, H. J., Shao, T., Song, B. et al. Cholesteryl ester accumulation induced by PTEN loss and PI3K/AKT activation underlies human prostate cancer aggressiveness. Cell Metab. 19, 393–406 (2014).

    Article  CAS  Google Scholar 

  31. Pascual, G., Avgustinova, A., Mejetta, S., Martin, M., Castellanos, A., Attolini, C. S. et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature 541, 41–45 (2017).

    Article  CAS  Google Scholar 

  32. Wu, H., Yu, J., Li, Y., Hou, Q., Zhou, R., Zhang, N. et al. Single-cell RNA sequencing reveals diverse intratumoral heterogeneities and gene signatures of two types of esophageal cancers. Cancer Lett. 438, 133–143 (2018).

    Article  CAS  Google Scholar 

  33. Li, C., Wang, Q., Ma, J., Shi, S., Chen, X., Yang, H. et al. Integrative pathway analysis of genes and metabolites reveals metabolism abnormal subpathway regions and modules in esophageal squamous cell carcinoma. Molecules 22, https://doi.org/10.3390/molecules22101599 (2017).

  34. Das, N., Topalovic, M. & Janssens, W. Artificial intelligence in diagnosis of obstructive lung disease: current status and future potential. Curr. Opin. Pulm. Med. 24, 117–123 (2018).

    Article  Google Scholar 

  35. Zhou, L. Q., Wang, J. Y., Yu, S. Y., Wu, G. G., Wei, Q., Deng, Y. B. et al. Artificial intelligence in medical imaging of the liver. World J. Gastroenterol. 25, 672–682 (2019).

    Article  Google Scholar 

Download references

Acknowledgements

We thank Dr. Z. Zhou for the analysis of transcriptomic data.

Author information

Author notes

  1. These authors contributed equally: Yuyao Yuan, Zitong Zhao, Liyan Xue.

Authors and Affiliations

  1. Department of Pathology, School of Basic Medical Sciences, Institute of Systems Biomedicine, Peking-Tsinghua Center for Life Sciences, Peking University Health Science Center, Beijing, China

    Yuyao Yuan, Guangxi Wang, Huajie Song, Ruifang Pang, Juntuo Zhou & Yuxin Yin

  2. State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

    Zitong Zhao & Yongmei Song

  3. Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

    Liyan Xue

  4. Institute of Precision Medicine, Peking University Shenzhen Hospital, Shenzhen, China

    Ruifang Pang & Yuxin Yin

  5. Department of Medical Genetics, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China

    Jianyuan Luo

Authors
  1. Yuyao Yuan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zitong Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Liyan Xue
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Guangxi Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Huajie Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ruifang Pang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Juntuo Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jianyuan Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yongmei Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Yuxin Yin
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Y. Yin. and Y.S. designed this study. Y. Yuan, H.S., G.W., J.Z. and R.P. conducted sample preparation and LC-MS analysis. Z.Z., L.X. and Y.S. collected clinical samples and clinical information and generated transcriptomic data. Y. Yuan and G.W. conducted data analysis and interpreted the data with J.Z., R.P. and L.J. Y. Yuan, Y.S. and Y. Yin wrote the manuscript.

Corresponding authors

Correspondence to Yongmei Song or Yuxin Yin.

Ethics declarations

Ethics approval and consent to participate

This study was performed in accordance with the Declaration of Helsinki and was conducted after obtaining approval from the Independent Ethics Committee at the National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (No. NCC2596). Informed consent was obtained from all patients or healthy controls. All methods were performed in accordance with relevant guidelines and regulations.

Consent to publish

Not applicable.

Data availability

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Competing interests

The authors declare no competing interests.

Funding information

This work was supported by grants to Y. Yin, including the National Key Research and Development Programme of China (2016YFA0500302 to Y. Yin), the National Natural Scientific Foundation of China (31420103905, 81321003, 81430056 and 81372491 to Y. Yin), the Beijing Natural Science Foundation (Key grant 7161007 to Y. Yin), the Shu Fan Education and Research Foundation (to Y. Yin), and Lam Chung Nin Foundation for Systems Biomedicine (to Y. Yin).

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yuan, Y., Zhao, Z., Xue, L. et al. Identification of diagnostic markers and lipid dysregulation in oesophageal squamous cell carcinoma through lipidomic analysis and machine learning. Br J Cancer 125, 351–357 (2021). https://doi.org/10.1038/s41416-021-01395-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41416-021-01395-w

This article is cited by

Search

Advanced search

Quick links